These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 5967371)

  • 21. Effect of hemagglutinin glycosylation on influenza virus susceptibility to neuraminidase inhibitors.
    Mishin VP; Novikov D; Hayden FG; Gubareva LV
    J Virol; 2005 Oct; 79(19):12416-24. PubMed ID: 16160169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiviral treatment of influenza in South Korea.
    Choe YJ; Lee H; Lee HJ; Choi EH
    Expert Rev Anti Infect Ther; 2015 Jun; 13(6):741-9. PubMed ID: 25835433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic effect of zanamivir-porphyrin conjugates on inhibition of neuraminidase and inactivation of influenza virus.
    Wen WH; Lin M; Su CY; Wang SY; Cheng YS; Fang JM; Wong CH
    J Med Chem; 2009 Aug; 52(15):4903-10. PubMed ID: 19522501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro effect of virazole against influenza viruses.
    Togo Y
    Antimicrob Agents Chemother; 1973 Dec; 4(6):641-2. PubMed ID: 4793883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Implications of Antiviral Resistance in Influenza.
    Li TC; Chan MC; Lee N
    Viruses; 2015 Sep; 7(9):4929-44. PubMed ID: 26389935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism-based covalent neuraminidase inhibitors with broad-spectrum influenza antiviral activity.
    Kim JH; Resende R; Wennekes T; Chen HM; Bance N; Buchini S; Watts AG; Pilling P; Streltsov VA; Petric M; Liggins R; Barrett S; McKimm-Breschkin JL; Niikura M; Withers SG
    Science; 2013 Apr; 340(6128):71-5. PubMed ID: 23429702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Screening based on response surface methodology of multi-fractions traditional Chinese medicine with anti-influenza virus neuraminidase activity: take shuanghuanglian injection as an example].
    Qiu LL; Chen LH; Yan D; Zhang P; Tan MR; Li ZM; Xiao XH
    Yao Xue Xue Bao; 2012 Apr; 47(4):466-71. PubMed ID: 22799028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Executive summary of the 6th meeting of the WHO Expert Working Group of the GISRS for Surveillance of Antiviral Susceptibility.
    Wkly Epidemiol Rec; 2017 Oct; 92(41):611-2. PubMed ID: 29028165
    [No Abstract]   [Full Text] [Related]  

  • 29. A drug-disease model describing the effect of oseltamivir neuraminidase inhibition on influenza virus progression.
    Kamal MA; Gieschke R; Lemenuel-Diot A; Beauchemin CA; Smith PF; Rayner CR
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5388-95. PubMed ID: 26100715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of some influenza virus strains isolated in Romania during the epidemics of 1971-1972.
    Teodosiu O; Sărăţeanu D; Popescu A; Mihail A
    Rev Roum Virol (1972); 1974; 11(2):171-7. PubMed ID: 4837820
    [No Abstract]   [Full Text] [Related]  

  • 31. Neuraminidase inhibitors as anti-influenza virus agents.
    Kim CU; Chen X; Mendel DB
    Antivir Chem Chemother; 1999 Jul; 10(4):141-54. PubMed ID: 10480735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From neuraminidase inhibitors to conjugates: a step towards better anti-influenza drugs?
    Cheng CK; Tsai CH; Shie JJ; Fang JM
    Future Med Chem; 2014 May; 6(7):757-74. PubMed ID: 24941871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A comparative study of the neuraminidase activity of 2 strains of influenza A2 type virus].
    Orlova NG; Mekhedov LN
    Vopr Virusol; 1970; 15(3):341-6. PubMed ID: 5472073
    [No Abstract]   [Full Text] [Related]  

  • 34. Screening and evaluation of commonly-used anti-influenza Chinese herbal medicines based on anti-neuraminidase activity.
    Han X; Zhang DK; Guo YM; Feng WW; Dong Q; Zhang CE; Zhou YF; Liu Y; Wang JB; Zhao YL; Xiao XH; Yang M
    Chin J Nat Med; 2016 Oct; 14(10):794-800. PubMed ID: 28236410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance to neuraminidase inhibitors.
    Dolin R
    Clin Infect Dis; 2011 Feb; 52(4):438-9. PubMed ID: 21248366
    [No Abstract]   [Full Text] [Related]  

  • 36. A study of the active site of influenza virus sialidase: an approach to the rational design of novel anti-influenza drugs.
    von Itzstein M; Dyason JC; Oliver SW; White HF; Wu WY; Kok GB; Pegg MS
    J Med Chem; 1996 Jan; 39(2):388-91. PubMed ID: 8558506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the effectiveness of two antiviral drugs and their combination.
    Altucci P; Varone GL; Magrassi F
    Chemotherapy; 1969; 14(3):140-50. PubMed ID: 5800407
    [No Abstract]   [Full Text] [Related]  

  • 38. Meeting of the WHO expert working group on surveillance of influenza antiviral susceptibility, Geneva, July 2013.
    Wkly Epidemiol Rec; 2013 Nov; 88(44/45):477-82. PubMed ID: 24236332
    [No Abstract]   [Full Text] [Related]  

  • 39. Pterocarpans and flavanones from Sophora flavescens displaying potent neuraminidase inhibition.
    Ryu YB; Curtis-Long MJ; Kim JH; Jeong SH; Yang MS; Lee KW; Lee WS; Park KH
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6046-9. PubMed ID: 18938076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Novel Potent and Highly Specific Inhibitor against Influenza Viral N1-N9 Neuraminidases: Insight into Neuraminidase-Inhibitor Interactions.
    Sriwilaijaroen N; Magesh S; Imamura A; Ando H; Ishida H; Sakai M; Ishitsubo E; Hori T; Moriya S; Ishikawa T; Kuwata K; Odagiri T; Tashiro M; Hiramatsu H; Tsukamoto K; Miyagi T; Tokiwa H; Kiso M; Suzuki Y
    J Med Chem; 2016 May; 59(10):4563-77. PubMed ID: 27095056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.